ChemAxon's New US East Coast Headquarters Open in Cambridge, MA

news · 9 years ago
ChemAxon, a leader in providing chemistry software solutions and consulting services for life science research, announces the opening of its new US East Coast headquarters in Cambridge, MA. Located at the heart of Boston’s biotechnology hub, these new offices will concentrate technical, scientific and consultancy support as well as business development operations. ChemAxon is also recruiting to meet strong growth in demand for its chemistry software in this region. ChemAxon sets the standard in chemically-intelligent software for new product R&D. With a client list that includes all of the top 15 global pharmas, the company continues to experience significant growth year on year. “Going forward our strategy is about developing the strong collaborative relationships we have with customers and business partners,” commented Alex Drijver, CEO of ChemAxon. “Locating in this key US pharma-biotech hub helps us ensure our technology evolves with customer requirements, and they gain more business value from their chemistry.” ChemAxon’s new US East Coast regional headquarters are at ChemAxon Services LLC, Cambridge Innovation Center, One Broadway, Cambridge, MA 02142, USA. About ChemAxon ChemAxon is a leader in providing cheminformatics software platforms and desktop applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions that power modern cheminformatics and chemical communication. The company is privately owned with European headquarters in Budapest, US East Coast headquarters in Cambridge, MA, and sales and support offices in Europe, Japan and across North America. A concise corporate profile for ChemAxon can be found at For further information please contact: Alex Allardyce ChemAxon Ltd. +361 453 0435 [email protected]